Anbogen Receives FDA Clearance to Initiate Phase 1/ 2 Trial of ABT-301 Triplet Therapy for Advanced Colorectal Cancer

Anbogen Therapeutics Taiwan United States of America United Kingdom

View original content:https://www.prnewswire.co.uk/news-releases/anbogen-receives-fda-clearance-to-initiate-phase-12-trial-of-abt-301-triplet-therapy-for-advanced-colorectal-cancer-302520502.html